The allergy diagnosis is an important introductory step for effective allergy treatment. Current allergy tests are more convenient and accurate compared to the tests that were available before. With the help of a detailed medical history, allergy tests can identify specific triggers for an individual�s allergic reactions. This process is also required in drug development and the production process of allergy treatments.

The allergy diagnostics market is projected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. The major factors driving the growth of this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and growing access to medical insurance in the US. On the other hand, lack of awareness of allergic diseases in some countries is restraining the growth of this market.

Assay kits to register the highest CAGR during the forecast period

The allergy diagnostics market is classified based on product & service into assay kits, instruments, and services. The assay kits segment is expected to grow at the highest rate during the forecast period. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.

Diagnostic laboratories to dominate the allergy diagnostics market during the forecast period

The allergy diagnosis market is segmented based on end users into diagnostic laboratories, hospital-based laboratories, academic & research institutes, and other end users. In 2017, the diagnostic laboratories segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to other segments. The market is mainly driven by the increasing incidence of allergic disorders in emerging countries.

Asia is estimated to be the fastest growing regional segment in the market during the forecast period

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities.

Market Dynamics

Driver: High incidence and large economic burden of allergic diseases

Allergy diagnostics is an important step in the treatment of patients suffering from allergic diseases. Major allergic diseases include asthma, rhinitis, angioedema, urticaria, conjunctivitis, and eczema, while conditions such as food allergies and drug and insect allergies also affect large population across the globe. According to an editorial piece published in the World Allergy Journal in May 2014, globally, ~300 million people suffer from asthma, and ~200 to 250 million people suffer from food allergies as of 2013.

According to the WHO, the total number of asthma patients globally is estimated to increase to 400 million by 2025. The economic burden of allergies includes both direct and indirect costs�direct costs include expenditure on medications and healthcare provisions while indirect costs include the costs associated with loss of work, social support, loss of taxation income, and lower productivity at work. Considering these factors, authorities in several countries are focusing on reducing the burden of allergic diseases in their respective healthcare systems. This, in turn, is expected to drive the demand for allergy diagnostics instruments and consumables in the coming years.

Opportunity: Growing adoption of automation for quicker turnaround times

Turnaround time (TAT) is an important factor in laboratory services and is often used as a key indicator of laboratory performance. Fully automated immunoassay systems are popular as they improve the TAT of laboratories and reduce labor costs. Semi-automated instruments are also preferred as they are less expensive; however, these systems increase the TAT. To meet the requirement of increased on-board testing capacity, advanced allergy diagnostic tests have been introduced in the market. Also, the market is witnessing greater adoption of automation for quicker TAT.

Automation in laboratories helps increase the efficiency of laboratory workflows, thus maintaining high throughputs. The main objective of automation in laboratories is to minimize nonvalue-adding steps, such as tube sorting, centrifugation, loading of analyzers, and preparing and sorting of materials required for testing. Some large laboratory chains are now shifting toward complete or total laboratory automation (TLA). However, these laboratories require major financial commitment.

Scope of the Report

Report Metric Details Market size available for years 2015�2022 Base year considered 2017 Forecast period 2017�2022 Forecast units Billion (USD) Segments covered Market report covers various types of Assay Kits, Instruments (Immunoassay Analyzers, Luminometers, ELISA Analyzers, Other Instruments), Services. Geographies covered North America (US and Canada), Europe (Germany, France, UK, Italy, Spain and RoE), Asia (Japan, China, India, and RoA), and LATAM (Brazil, Mexico and Rest of LATAM) and Middle East and Africa Companies covered Major 10 players covered, including: Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioM�rieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US).

The research report categorizes the allergy diagnostics market into the following segments and sub-segments:

Allergy Diagnostics Market, by Product & Service

Assay Kits

Instruments Immunoassay Analyzers Luminometers ELISA Analyzers Other Instruments

Services

Allergy Diagnostics Market, by Test Type

In Vivo Tests

In Vitro Tests

Allergy Diagnostics Market, by Allergen

Inhaled Allergens

Food Allergens

Drug Allergens

Other Allergens

Allergy Diagnostics Market, by End User

Diagnostics Laboratories

Hospital-based Laboratories

Academic and Research Institutes

Other End Users

Allergy Diagnostics Market, by Region

North America US Canada

Europe Germany UK France Italy Spain Rest of Europe (RoE)

Asia China Japan India Rest of Asia (RoA)

Latin America Brazil Mexico Rest of Latin America

Middle East and Africa

Pacific and Oceania

Key Market Players

Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK) and Hitachi Chemical Co., Ltd. (Japan).

Recent Developments

Critical questions the report answers

Where will all these developments take the industry in the long term?

What are the upcoming trends for the allergy diagnostics market?

Which segment provides the most opportunity for growth?

Who are the leading vendors operating in this market?

What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst